// App-Quantinova.ai

500 : Prognostic impact of CTC detected using a novel fluidic cell microarray chip CTC detection system in patients with breast cancer

Researchers

Presenter

  • Takeshi Sawada

Principal Investigators

  • Toshinari Yamashita

  • Manami Masubuchi

  • Tsuneko Chiyoda

  • Mayu Yunokawa

  • Kumiko Hoshi

  • Shoichi Tao

  • Shohei Yamamura

  • Shouki Yatsushiro

  • Kaori Abe

  • Masatoshi Kataoka

  • Tatsu Shimoyama

  • Yoshiharu Maeda

  • Katsumasa Kuroi

  • Kenji Tamura

  • Tsuneo Sawazumi

  • Hironobu Minami

  • Yoshihiko Suda

  • Fumiaki Koizumi

Medical Centers

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

  • Konica Minolta, Inc., Tokyo, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • Health Research Institute, National Institute of Advanced Industrial Science and Technology, Kagawa, Japan

  • Kyoto University Graduate School of Medicine, Kyoto, Japan

Locations

  • Japan

Companies

  • Konica Minolta Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved